AMGN

Nasdaq

AMGEN INC

Health Care, Biotechnology

$410.95

close 7 Aug 2026

+44.15%

52-week change

$222.16B

market cap

$269.77

$418.40

52-week range

Expected price

$339.39 – $414.81

Current price

$410.95

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)25.54x

P/S (TTM)5.83x

P/B19.01x

EV/EBITDA (TTM)16.26x

FCF yield (TTM)4.58%

PEG (TTM, GAAP)4.62

Context

P/E, own 5-year average26.68x

P/E, sector median29.65x*

Price at 5-year median P/E$376.54*

Indicated dividend yield2.45%

Forward — analyst consensus

Forward P/E (FY2026)17.97x*

Forward P/E (FY2027)17.12x

Forward PEG3.60*

Consensus EPS FY2026 (31 analysts)$22.87

EPS growth (FY2026→FY2027)4.99%

Revenue growth (FY2026)5.65%

Street view

Price target (mean)$374.69*

Target upside-8.82%

Ratings (buy / hold / sell)14 / 16 / 4

FY2026 EPS revisions, 30d (up / down)3 / 12

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -3.91%10Y CAGR -1.20%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$410.95

Cash & equivalents$13.99B

Total debt$57.30B

Shares outstanding540.60M

Result

DCF price per share$133.56

Current price$410.95

Margin of safety-67.50%

PV of years 1–10$56.57B

PV of terminal value$58.94B

Equity value$72.20B

Market-implied growth+6.81%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$9.78B	$9.39B	$9.03B	$8.67B	$8.34B	$8.01B	$7.70B	$7.40B	$7.11B	$6.83B	$127.26B
PV	$9.05B	$8.05B	$7.17B	$6.38B	$5.67B	$5.05B	$4.49B	$4.00B	$3.55B	$3.16B	$58.94B

period to 30 Jun 2026, filed 5 Aug 2026, close 7 Aug 2026